Whole genome sequencing revealed high proportions of ST152 MRSA among clinical Staphylococcus aureus isolates from ten hospitals in Ghana
2024

High Proportions of ST152 MRSA Found in Clinical Staphylococcus aureus Isolates in Ghana

Sample size: 159 publication 10 minutes Evidence: high

Author Information

Author(s): Beverly Egyir, Christian Owusu-Nyantakyi, Alfred Bortey, Rabbi Amuasi Grebstad, Felicia Amoa Owusu, William Boateng, Hawawu Ahmed, Justice Kwesi Danso, Agnes Akosua Gyamaah Oclu, Quaneeta Mohktar, Georgina Tetteh-Ocloo, Harold Amegbletor, Kwabena Fosu, Francis Kwame Morgan Tetteh, Solomon Asante-Sefa, Oliver Nangkuu Deberu, Kennedy Mensah Osei, Joana Twasam, Sarkodie Kodom, Esther Gyinae, James Sampah, Nicholas Dzifa Dayie, Noah Obeng-Nkrumah, William Addo Mills-Pappoe, Gifty Boateng, Pernille Nilsson, Harriet Affran Bonful, Bright Adu, Rene S. Hendriksen

Primary Institution: Noguchi Memorial Institute for Medical Research, University of Ghana

Hypothesis

What is the prevalence and genetic characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among clinical isolates in Ghana?

Conclusion

The study found a high prevalence of ST152 MRSA among clinical isolates in Ghana, indicating a shift in the epidemiological landscape of these pathogens.

Supporting Evidence

  • 38% of the isolates were found to be methicillin-resistant.
  • 74% of the ST152 clones harbored the mecA gene.
  • 65% of the isolates carried the Panton-Valentine leucocidin (PVL) gene.
  • 23 different genes associated with antimicrobial resistance were identified.
  • High prevalence of virulence genes was observed among the isolates.

Takeaway

Researchers looked at bacteria from sick people in Ghana and found a lot of a specific type that is hard to treat. This means doctors need to be careful and keep checking for these germs.

Methodology

Whole genome sequencing was used to analyze 159 Staphylococcus aureus isolates from clinical sources across ten hospitals in Ghana.

Limitations

The study may be limited by the representativeness of the sample and the capacity for molecular data analysis in Ghana.

Participant Demographics

Isolates were obtained from clinical samples including wound, blood, urine, and other sources from ten hospitals in Ghana.

Digital Object Identifier (DOI)

10.1128/msphere.00446-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication